FX & CFD trading involves significant risk
Johnson & Johnson (JNJ) earned $1.27 per share in the fourth quarter, beating analysts' estimate of $1.25. Revenue in the fourth quarter decreased 0.6% year-over-year to $18.25 billion, missing analysts' estimate of $18.53 billion.
The company forecast $6.12-$6.27 per share in 2015 (analysts' estimate: $6.15 per share).
Johnson & Johnson (JNJ) shares increased to $103.25 (-0.76%) prior to the opening bell.
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.